Shareholder Activities
2019-2020 NWCRI Shareholder Activities
NWCRI members are bringing 14 justice issues to the boardrooms of 48 corporations, filing 31 shareholder resolutions* and participating in over 50 dialogues.
| Company | Issue |
|
| AbbVie | Executive Compensation & Drug Pricing Risks |
|
| AbbVie | Global Health |
|
| Alphabet | Child Sexual Exploitation Online |
|
| Altria Group* | Discourage Nicotine Use Among Youth |
|
| Amazon | Facial Recognition Software-Customer Due Diligence |
|
| Amer. Outdoors Brands | Develop a Human Rights Policy |
|
| Amgen | Senior Executive Incentives – Integrate Drug Pricing Risk |
|
| AT&T | Child Sexual Exploitation Online |
|
| Biogen | Executive Compensation & Drug Pricing Risks |
|
| Bristol-Myers Squibb* | Independent Board Chair |
|
| Bristol-Myers Squibb | Global Health |
|
| Campbell Soup | Health Outcomes Related to Diet/Human Right to Water |
|
| Cardinal Health | Establish Deferral Period for Senior Exec Bonuses |
|
| Caterpillar | Lobbying Expenditures Disclosure |
|
| Chevron* | Evaluation of Human Rights Practices |
|
| Chevron | Plans to Align Operations with Paris Treaty |
|
| Coca-Cola | Water Stewardship/Sustainable Agriculture |
|
| Comcast* | Lobbying Expenditures Disclosure |
|
| CoreCivic | Private Prisons/Human Rights Due Diligence |
|
| CVS Health | Establish Deferral Period for Senior Exec Bonuses |
|
| Disney | Tobacco Depiction Policy in Media |
|
| Dick’s Sporting Goods | Gun Safety |
|
| Duke Energy* | Report on Mitigation of Health & Climate Impacts of Coal |
|
| Eli Lilly | Executive Compensation & Drug Pricing Risks |
|
| Eli Lilly | Global Health |
|
| ExxonMobil | Plans to Align Operations with Paris Treaty |
|
| Independent Board Chair |
|
|
| Freeport McMoRan | Human Rights |
|
| General Mills | Health Outcomes Related to Diet |
|
| GEO Group | Private Prisons/Human Rights Due Diligence |
Dialogue
|
| Gilead Sciences | Independent Board Chair |
|
| Gilead Sciences | Global Health |
|
| Hershey | Human Rights Due Diligence in Supply Chain |
|
| Johnson & Johnson | Board Report on Oversight of Opioids |
|
| Johnson & Johnson | Independent Board Chair |
|
| Johnson & Johnson | Global Health |
|
| JP Morgan Chase | Project Financing in Arctic & Canadian Oil Sands | Resolution 15% |
| Kraft Heinz | Human Rights | Dialogue |
| Kroger | Human Rights Due Diligence in Supply Chain |
|
| McDonald’s | Health Outcomes Related to Diet |
|
| Merck | Global Health |
|
| Merck | Senior Executive Incentives – Integrate Drug Pricing Risk |
|
| Mylan | Monitor & Manage Risks Related to Opioids |
|
| Newmont Mining | Human Rights Supplier Standards |
|
| Northrop Grumman* | Human Rights Supplier Standards |
|
| Olin | Safety in Firearms Industry-Ammunition |
|
| PepsiCo | Water/Reduce Pesticide/Pollinator Health |
|
| Pfizer | Executive Compensation & Drug Pricing Risks |
|
| Pfizer | Global Health |
|
| Pfizer | Independent Board Chair |
|
| Sanofi | Global Health/Drug Pricing |
|
| Sturm Ruger | Human Rights Impact Assessment |
|
| Tyson Foods | Human Rights Due Diligence |
|
| Walgreens Boot Alliance | Establish Deferral Period for Senior Exec Bonuses |
|
| Walgreens Boot Alliance | Tobacco Sales |
|
| Walmart* | Board Oversight – Risks Related to Opioids |
|
| Walmart | Wages & Benefits for Employees |
|
| Walmart | Human Rights Due Diligence in Supply Chain |
|
| Walmart | Gun Safety |
|
| Wells Fargo | Business Standards/Vision & Values/Risk Management |
|
*Resolutions filed by the Sisters of St. Francis of Philadelphia from their office